PHI with Ulcerative (chronic) enterocolitis
How does this condition affect your private health insurance?
Ulzeröse (chronische) Enterokolitis denotes a chronic inflammatory bowel disease characterized by persistent inflammation and ulceration affecting both the small and large intestines. This condition manifests with severe abdominal pain, chronic, often bloody diarrhea, significant weight loss, fatigue, and fever. It follows a course of remissions and relapses, profoundly impacting patient quality of life. Complications can include strictures, fistulas, nutritional deficiencies, and an elevated risk of colorectal cancer over time. Diagnosis typically involves endoscopic examination, biopsies, and advanced imaging. Treatment strategies focus on managing inflammation, alleviating symptoms, and preventing long-term complications through medication and sometimes surgery.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months, often requiring hospitalization for acute management.
Duration of Illness (Lifetime)
Chronic disease, lifelong with periods of remission and relapse.
Cost of Treatment (Initial)
High, typically involving thousands to tens of thousands of USD due to diagnostics, hospitalization, and initial specialized medications.
Cost of Treatment (Lifetime)
Very high, cumulative costs can reach hundreds of thousands of USD over a lifetime due to chronic medication (e.g., biologics), regular monitoring, and potential surgeries.
Mortality Rate
Low to moderate, significantly increased in cases of severe complications like toxic megacolon, bowel perforation, severe hemorrhage, or associated malignancy.
Risk of Secondary Damages
High (e.g., malnutrition, anemia, strictures, fistulas, abscesses, colorectal cancer risk, arthritis, skin lesions, eye inflammation, anxiety, depression).
Probability of Full Recovery
Very low; as a chronic inflammatory bowel disease, true complete recovery without recurrence is rare, though sustained remission is a treatment goal.
Underlying Disease Risk
Moderate (e.g., other autoimmune conditions, genetic predispositions; it is typically a primary diagnosis itself rather than secondary to another disease, but comorbidities are common).